Wallstent与Venovo支架治疗非血栓性髂静脉流出道狭窄短期结局的实践审计
该回顾性分析随机抽取2018年4月至2020年12月间100例Wallstent(WS)和100例Venovo支架(VS)病例,比较并发症与再干预率。两组再干预率相似(WS 5例 vs VS 4例,P=0.74),一过性背痛最常见(WS 37% vs VS 47%,P=0.28)。VS直径更小、长度更长,更常覆盖髂总与髂外静脉。
要点
- 两组再干预率相似:WS 5例 vs VS 4例(P=0.74)。
- 一过性背痛最常见:WS 37% vs VS 47%(P=0.28)。
- VS直径更小、长度更长,更常覆盖髂总与髂外静脉。
核心结论
- WS与VS两组并发症率和再干预率相似。
- 两种支架均出现需再干预的支架内狭窄。
- 植入的VS倾向于直径更小、长度更长,且较WS更常覆盖髂总与髂外静脉。
- 因此,一个VS可覆盖两个区域,而WS需两个支架覆盖相同静脉区域长度。
研究设计与样本
- 回顾性分析随机抽取2018年4月至2020年12月期间施行的100例WS和100例VS病例。
- 评估人口学特征、就诊症状和CEAP分类。
- 审查每例的并发症记录和90天随访数据,评估术后深静脉血栓、支架血栓、支架内再狭窄、出血和一过性背痛的发生率。
主要发现
- WS更多置于左髂总静脉段(52 vs 1),VS更多置于左髂总静脉和髂外静脉段(36 vs 63;P=0.0069)。
- WS与VS平均直径分别为19.7±2.2 mm vs 15±1.4 mm(P=2.4×10⁻⁴⁴),平均长度分别为80.8±9 mm vs 117.6±20.4 mm(P=2.4×10⁻³⁸)。
- 每例患者平均支架数:WS 1.05 vs VS 1.03(P=0.47)。
- 再干预率:WS 5例 vs VS 4例(P=0.74);WS 5例再干预中4例为支架延伸治疗支架内再狭窄和症状复发,1例为闭塞需同侧静脉成形和支架置入;VS 4例再干预中2例为静脉成形治疗支架内再狭窄,2例为支架延伸治疗症状复发。
- 一过性背痛最常见:WS 37% vs VS 47%(P=0.28);穿刺点深静脉血栓:WS组3例 vs VS组4例(P=0.71);无患者发生需住院的出血,无支架断裂、支架移位或死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Wallstent (WS; Boston Scientific, Malborough, MA) is currently the standard of care for comparisons of clinical efficacy for new stent devices in the treatment of iliac vein outflow disease. Many vein-specific Nitinol-based stents have been now approved by the Food and Drug Administration for use in the iliofemoral venous system. However, few comparisons of these devices to the current standard have been reported. The purpose of this investigation was to compare the complication and reintervention rates between the WS and Venovo stent (VS; BD, Franklin Lakes, NJ). METHODS: A random sample of 100 WS and 100 VS cases performed from April 2018 through December 2020 were selected for retrospective analysis. The demographics, presenting symptoms, and CEAP (Clinical, Etiology, Anatomy, Pathophysiology) class were assessed. The complication logs and 90-day follow-up data were reviewed for every case to assess the incidence of postoperative deep vein thrombosis, stent thrombosis, in-stent restenosis, bleeding, and transient back pain. RESULTS: WSs had been placed more often in the left common iliac vein segment (52 vs 1), and VSs had been placed more often in the left common iliac vein and external iliac vein segments (36 vs 63; P = .0069). The average diameter and length of the WSs and VSs were 19.7 ± 2.2 mm vs 15 ± 1.4 mm (P = 2.4∗10-44) and 80.8 ± 9 mm vs 117.6 ± 20.4 mm (P = 2.4∗10-38), respectively. The average number of stents per patient was 1.05 for the WSs and 1.03 for the VSs (P = .47). The reintervention rates were similar between the two groups: WS, n = 5; and VS, n = 4 (P = .74). Four of the five WS reinterventions were stent extensions to treat in-stent restenosis and recurrence of symptoms, and one was secondary to occlusion requiring ipsilateral venoplasty and stenting. Two of the four VS reinterventions were venoplasty for in-stent restenosis and two were stent extensions for symptom recurrence. Transient back pain was the most common complication (WS, 37%; VS, 47%; P = 0.28). Insertion site deep vein thrombosis had developed in the three patients in the WS group and four patients in the VS group (P = .71). No patient had experienced bleeding requiring hospitalization, and no stent fractures, stent migration, or deaths had occurred. CONCLUSIONS: The complication and reintervention rates between the WS and VS groups were similar. Both stents demonstrated evidence of in-stent stenosis requiring reintervention. Implanted VSs tended to be smaller in diameter and longer in length and covered the common and external iliac veins more often compared with the WSs. Therefore, one VS can be used to cover two territories compared with the WS for which two stents will be required to cover the same vein territory length.
引用
- Sulakvelidze L, Lakhanpal G, Lakhanpal S, et al. A practice audit of short-term outcomes of Wallstents versus Venovo stents for the treatment of nonthrombotic iliac vein outflow stenoses. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 36182087. doi:10.1016/j.jvsv.2022.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。